38 component-labeling-cuda Fellowship positions at UNIVERSITY OF SOUTHAMPTON in United Kingdom
Sort by
Refine Your Search
-
, you will lead a wide range of optical fabrication and characterisation activities, working side-by-side with researchers to develop the world's lowest-loss on-chip optical resonators. A core part of
-
). Proficiency in computational tools such as ANSYS, LS-DYNA3D, Abaqus, or similar FEA software. Excellent written and verbal communication skills. Ability to work independently and as part of a team. What do we
-
resonators. A core part of this role will involve close collaboration with the California Institute of Technology (Caltech) and inter-institute visits to drive the project forward and translate our research
-
, microphone array design, and portable device technology. You’ll be part of a vibrant, multi-disciplinary research environment, drawing expertise from across the University of Southampton, and helping to shape
-
from sustainable and durable materials that can be retrofitted to existing transformer enclosures. Transformer noise, particularly its low-frequency tonal components, poses significant challenges
-
. Working as part of a multi-partner Innovate UK funded project we are seeking highly motivated individuals to join us in the development of digital engineering technologies to accelerate the design of
-
model, suited to integrated system modelling, and to contribute to centrifuge testing of novel anchors You will be involved in the holistic design of floating wind systems as part of a large team with
-
noise, particularly its low-frequency tonal components, poses significant challenges for conventional noise control methods. Acoustic metamaterials offer a promising alternative by breaking their acoustic
-
% cancer, 25% non-cancer) that covers the complete spectrum of clinical practice. As part of our CRUK and NIHR infrastructure, we have close working relationships with our partners, including the Southampton
-
publication of clinical trials and other well-designed studies, managing a growing portfolio (75% cancer, 25% non-cancer) that covers the complete spectrum of clinical practice. As part of our CRUK and NIHR